+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Emerging Pharmaceuticals Markets in China

  • PDF Icon

    Report

  • 238 Pages
  • September 2023
  • Region: China
  • AMID Co
  • ID: 2886070

China's demand for Emerging Pharmaceuticals will continue to grow at 12% by 2032

China's demand for Emerging Pharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

Table of Contents

I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
II. BUSINESS ENVIRONMENT
  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties
III. EMERGING PHARMACEUTICALS INDUSTRY ASSESSMENTS
  • Emerging Pharmaceuticals Industry Structure
  • Market Size
  • Market Growth Driver
  • Emerging Pharmaceuticals Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development
IV. EMERGING PHARMACEUTICALS SALES VOLUMES AND FORECASTS
  • Overview
  • Emerging Pharmaceuticals Sales Volumes and Forecasts
  • Vaccines
  • Infectious Disease Treatment Drugs
  • Cardiovascular Treatment Drugs
  • Cancer Treatment Drugs
  • HIV Treatment Drugs
  • Emerging Pharmaceuticals Imports and Exports
  • Pricing Trends
V. EMERGING PHARMACEUTICALS MARKET OUTLOOK
  • Emerging Pharmaceuticals Markets Outlook
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits
VI. MARKETING STRATEGIES
  • China Market Entry Overview
  • China’s Distribution System
  • Emerging Pharmaceuticals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China’s Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises
VII. EMERGING PHARMACEUTICALS PRODUCER DIRECTORY
  • Emerging Pharmaceuticals Producer Profiles and Directory
LIST OF TABLES
I. INTRODUCTION
  • Economic Outlook Summary
  • Emerging Pharmaceuticals Sales Volume
II. BUSINESS ENVIRONMENT
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
III. EMERGING PHARMACEUTICALS INDUSTRY ASSESSMENTS
  • Emerging Pharmaceuticals Sales Volume
  • Major Producer Facility Location
  • Major Emerging Pharmaceuticals Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investment in China
IV. EMERGING PHARMACEUTICALS SALES VOLUMES AND FORECASTS
  • Overview
  • Emerging Pharmaceuticals Sales Volumes and Forecasts
  • Vaccines
  • Infectious Disease Treatment Drugs
  • Cardiovascular Treatment Drugs
  • Cancer Treatment Drugs
  • HIV Treatment Drugs
  • Emerging Pharmaceuticals Imports and Exports
V. EMERGING PHARMACEUTICALS MARKET OUTLOOK
  • Total Emerging Pharmaceuticals Sales Volume by Market
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION
  • Economic Outlook Summary
  • China’s Emerging Pharmaceuticals Sales Volume
II. BUSINESS ENVIRONMENT
  • China’s GDP and Growth Rate
  • Specialty Output by Ownership
  • China’s Imports and Exports
III. EMERGING PHARMACEUTICALS INDUSTRY ASSESSMENTS
  • Emerging Pharmaceuticals Sales Volume
IV. EMERGING PHARMACEUTICALS SALES VOLUMES AND FORECASTS
  • Overview
  • Emerging Pharmaceuticals Sales Volumes and Forecasts
  • Vaccines
  • Infectious Disease Treatment Drugs
  • Cardiovascular Treatment Drugs
  • Cancer Treatment Drugs
  • HIV Treatment Drugs
  • Emerging Pharmaceuticals Imports and Exports
V. EMERGING PHARMACEUTICALS MARKET OUTLOOK
  • Total Emerging Pharmaceuticals Sales Volume by Market
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits
IV. MARKETING STRATEGIES
  • China’s Distribution Channel

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Roche China
  • GlaxoSmithKline China